4
Changes in Ownership
RxSight, Inc. Filed Acc 0000950170-23-067110
Director sold 494,313 shares at an average $29.73 ($14,695,695)
- Director disposed of 445,400 shares (other)
- Director acquired 2,310 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tammenoms Bakker Juliet Director | 2023-11-28 | Sale | −145,068 | $29.62 | $4,297,030 | 349,245 | I |
| Tammenoms Bakker Juliet Director | 2023-11-29 | Sale | −349,245 | $29.77 | $10,398,665 | 0 | I |
| Tammenoms Bakker Juliet Director | 2023-11-30 | Other disposition | −445,400 | 0 | I | ||
| Tammenoms Bakker Juliet Director | 2023-11-30 | Other acquisition | +693 | 1,548 | I | ||
| Tammenoms Bakker Juliet Director | 2023-11-30 | Other acquisition | +1,617 | 21,840 | D | ||
| Open-market sales · 494,313 sh · avg $29.73 · $14,695,695 | |||||||
Loading xslF345X05/ownership.xml…